Microdose Journal

Scientific News, Journal Papers, Studies for Microdosing for Mental Health

Menu
  • About MicrodoseJournal.com
  • Conferences
  • Contact
  • Find Psychedelic Therapy Providers:
  • News
  • Psychedelic Studies & Research Centers
  • Retreats
  • Scientific Papers
  • Video
Menu

Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans

Posted on January 15, 2020January 15, 2020 by Research

John H. Halperna,,Correspondence information about the author John H. HalpernEmail the author John H. Halpern, Andrea R. Sherwoodc, James I. Hudsona, Deborah Yurgelun-Toddb, Harrison G. Pope Jra

Halpern, John H. et al.Biological Psychiatry, Volume 58, Issue 8, 624 – 631

Background

Hallucinogens are widely used, both by drug abusers and by peoples of traditional cultures who ingest these substances for religious or healing purposes. However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood.

Methods

We recruited three groups of Navajo Native Americans, age 18–45: 1) 61 Native American Church members who regularly ingested peyote, a hallucinogen-containing cactus; 2) 36 individuals with past alcohol dependence, but currently sober at least 2 months; and 3) 79 individuals reporting minimal use of peyote, alcohol, or other substances. We administered a screening interview, the Rand Mental Health Inventory (RMHI), and ten standard neuropsychological tests of memory and attentional/executive functions.

Results

Compared to Navajos with minimal substance use, the peyote group showed no significant deficits on the RMHI or any neuropsychological measures, whereas the former alcoholic group showed significant deficits (p < .05) on every scale of the RMHI and on two neuropsychological measures. Within the peyote group, total lifetime peyote use was not significantly associated with neuropsychological performance.

Conclusions

We found no evidence of psychological or cognitive deficits among Native Americans using peyote regularly in a religious setting. It should be recognized, however, that these findings may not generalize to illicit hallucinogen users.

References

  1. IL; 1966
    • Google Scholar
  2. Albaugh, B.J., Anderson, P.O. Peyote in the treatment of alcoholism among Native Americans. Am J Psychiatry. 1974;131:1247–1250
    • PubMed
    • Google Scholar
  3. American Indian Religious Freedom Act Amendments of 1994 (1994): 108 Statute 3124 Public Law 103-344. 42 USC.
    • Google Scholar
  4. American Psychiatric Association. in: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Press, Washington, DC; 1994
    • Google Scholar
  5. Bergman, R.L. Navajo peyote use (Its apparent safety) . Am J Psychiatry. 1971;128:695–699
    • PubMed
    • Google Scholar
  6. Blum, K., Futterman, S.L., Pascarosa, P. Peyote, a potential ethnopharmacologic agent for alcoholism and other drug dependencies (Possible biochemical rationale) . Clin Toxicol. 1977;11:459–472
    • Crossref
    • | PubMed
    • | Scopus (10)
    • Google Scholar
  7. Burke, H.R. Raven’s Progressive Matrices (More on norms, reliability, and validity) . J Clin Psychol. 1985;41:231–235
    • Crossref
    • | Scopus (43)
    • Google Scholar
  8. Calabrese, J.D. Spiritual healing and human development in the Native American Church (Toward a cultural psychiatry of peyote) . Psychoanal Rev. 1997;84:237–255
    • PubMed
    • Google Scholar
  9. Davies, A.R., Sherbourne, C.D., Peterson, J.R., Ware, J.E. Scoring Manual. RAND Corporation, Santa Monica, CA; 1988
    • Google Scholar
  10. de Rios, M.D., Grob, C.S., Baker, J.R. Hallucinogens and redemption. J Psychoactive Drugs. 2002;34:239–248
    • Crossref
    • | PubMed
    • | Scopus (33)
    • Google Scholar
  11. Garrity, J.F. Jesus, peyote, and the holy people (Alcohol abuse and the ethos of power in Navajo healing) . Med Anthropol Q. 2000;14:521–542
    • Crossref
    • | PubMed
    • | Scopus (22)
    • Google Scholar
  12. Glick, S.D., Maisonneuve, I.M. Development of novel medications for drug addiction. The legacy of an African shrub. Ann N Y Acad Sci. 2000;909:88–103
    • Crossref
    • | PubMed
    • Google Scholar
  13. Grant, I. Alcohol and the brain (Neuropsychological correlates) . J Consult Clin Psychol. 1987;55:310–324
    • Crossref
    • | PubMed
    • Google Scholar
  14. Grinspoon, L., Bakalar, J.B. Psychedelic Drugs Reconsidered. The Lindesmith Center, New York; 1997
    • Google Scholar
  15. Grob, C.S. Psychiatric research with hallucinogens (What have we learned?) . Yearbook for Ethnomedicine and the Study of Consciousness. 1994;3:91–112
    • Google Scholar
  16. Halpern, J.H. The use of hallucinogens in the treatment of addiction. Addict Res. 1996;4:177–189
    • Crossref
    • Google Scholar
  17. Halpern, J.H., Pope, H.G. Do hallucinogens cause residual neuropsychological toxicity?. Drug Alcohol Depend. 1999;53:247–256
    • Abstract
    • | Full Text
    • | Full Text PDF
    • | PubMed
    • | Scopus (36)
    • Google Scholar
  18. Halpern, J.H., Pope, H.G. Hallucinogen persisting perception disorder (What do we know after 50 years?) . Drug Alcohol Depend. 2003;69:109–119
    • Abstract
    • | Full Text
    • | Full Text PDF
    • | PubMed
    • | Scopus (101)
    • Google Scholar
  19. Halpern, J.H., Pope, H.G., Sherwood, A.R., Barry, S., Hudson, J.I., Yurgelun-Todd, D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004;75:135–147
    • Abstract
    • | Full Text
    • | Full Text PDF
    • | PubMed
    • | Scopus (106)
    • Google Scholar
  20. Heaton, R. Wisconsin Card Sorting Test Manual. Psychological Assessment Resources, Odessa, FL; 1981
    • Google Scholar
  21. Hollister, L.E., Sjoberg, B.M. Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin, and a combination of the three psychomimetic drugs. Compr Psychiatry. 1964;20:170–178
    • Abstract
    • | Full Text PDF
    • | Scopus (16)
    • Google Scholar
  22. Jastak Associates. Wide Range Achievement Test, Revision 3. ; 1993 (Division of Wide Range, 15 Ashley Place, Suite 1A, Wilmington, DE 19804-1314.)
    • Google Scholar
  23. Johnston, L.D., O’Malley, P.M., Bachman, J.G. Monitoring the Future national results on adolescent drug use. National Institute on Drug Abuse, Bethesda, MD; 2003
    • Google Scholar
  24. La Barre, W. in: The Peyote Cult. 5th ed. University of Oklahoma Press, Tulsa; 1989
    • Google Scholar
  25. Lamarine, R.J. Alcohol abuse among Native Americans. J Community Health. 1988;13:143–155
    • Crossref
    • | PubMed
    • | Scopus (23)
    • Google Scholar
  26. MacLeod, C. Half a century of research on the Stroop effect (An integrative review) . Psychol Bull. 1991;109:163–203
    • Crossref
    • | PubMed
    • | Scopus (3436)
    • Google Scholar
  27. Mail, P.D., Johnson, S. Boozing, sniffing, and toking (An overview of the past, present, and future of substance use by American Indians) . Am Indian Alsk Native Ment Health Res. 1993;5:1–33
    • Crossref
    • | PubMed
    • Google Scholar
  28. Manson, S., Shore, J., Baron, A., Ackerson, L., Neligh, G. Alcohol abuse and dependence among American Indians. in: J.E. Helzer, G.J. Canino (Eds.) Alcoholism in North America, Europe, and Asia. Oxford University Press, New York; 1992:119–130
    • Google Scholar
  29. Menninger, K. Discussion of Bergman RL (1971): Navajo peyote use: Its apparent safety. (Am J Psychiatry 128:695-699)Am J Psychiatry. 1971;128:699
    • Google Scholar
  30. Nichols, D.E. Hallucinogens. Pharmacol Ther. 2004;101:131–181
    • Crossref
    • | PubMed
    • | Scopus (694)
    • Google Scholar
  31. Nichols, D.E., Pfister, W.R., Yim, G.K.W., Cosgrove, R.J. A new view of the structural relationship between LSD and mescaline. Brain Res Bull. 1977;2:169–171
    • Crossref
    • | PubMed
    • | Scopus (17)
    • Google Scholar
  32. Osterrieth, P. Le test de copie d’une figure complexe. Archives de Psychologie. 1944;30:206–356
    • Google Scholar
  33. Parrott, A.C. Human psychopharmacology of Ecstasy (MDMA) (A review of 15 years of empirical research) . Hum Psychopharmacol. 2001;16:557–577
    • Crossref
    • | PubMed
    • | Scopus (270)
    • Google Scholar
  34. Pope, H.G. Cannabis, cognition, and residual confounding. JAMA. 2002;287:1172–1174
    • Crossref
    • | PubMed
    • Google Scholar
  35. Pope, H.G., Gruber, A.J., Hudson, J.I., Huestis, M.A., Yurgelun-Todd, D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001;58:909–915
    • Crossref
    • | PubMed
    • | Scopus (470)
    • Google Scholar
  36. Pope, H.G., Gruber, A.J., Yurgelun-Todd, D. Residual neuropsychological effects of cannabis. Curr Psychiatry Rep. 2001;3:507–512
    • Crossref
    • | PubMed
    • | Scopus (67)
    • Google Scholar
  37. Reitan, R., Wolfson, D. The Halstead-Reitan Neuropsychological Test Battery (Theory and Clinical Interpretation) . 2nd ed. Neuropsychology Press, Tuson, AZ; 1993
    • Google Scholar
  38. Roy, C. Indian peyotists and alcohol. (letter to the editor)Am J Psychiatry. 1973;130:329–330
    • PubMed
    • Google Scholar
  39. Shulgin, A.T., Sargent, T., Naranjo, C. Structure–activity relationships of one-ring psychotomimetics. Nature. 1969;221:537–541
    • Crossref
    • | PubMed
    • | Scopus (188)
    • Google Scholar
  40. Slotkin, J.S. in: The Peyote Religion. 1st ed. The Free Press, Glencoe, IL; 1956
    • Google Scholar
  41. Snyder, S.H., Merril, C.R. A quantum-chemical correlate of hallucinogenesis. in: H.E. Himwich, S.S. Kety, J.R. Smythies (Eds.) Amines and Schizophrenia. Pergamon Press, Oxford; 1967:229–245
    • Google Scholar
  42. Stewart, O. Peyote Religion (A History) . 1st ed. University of Oklahoma Press, Tulsa; 1987
    • Google Scholar
  43. Stroop, J. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–662
    • Crossref
    • | Scopus (10357)
    • Google Scholar
  44. Veit, C.T., Ware, J.E. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51:730–742
    • Crossref
    • | PubMed
    • | Scopus (1164)
    • Google Scholar
  45. Wechsler, D. A standardized memory scale for clinical use. J Clin Psychol. 1945;19:87–95
    • Google Scholar
  46. Wechsler, D. Wechsler Adult Intelligence Scale-Revised Manual. Psychological Corp, Cleveland, OH; 1981

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About This Site

The Microdose Journal provides scientific studies and articles relating to the phenomenon of microdosing for the improvement of mental health.  It is also a resource for major study centers, conferences, and therapy centers that utilize psychedelics.

Recent Posts

  • A Review of LSD Treatment in Alcoholism
  • Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
  • The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
  • The ethics of psychedelic research in disorders of consciousness
  • Psychedelic Support
  • Santa Cruz, California City Council Approves Decriminalization Measure Measure for Psychedelics
  • Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
  • Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
  • Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
  • The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving
© 2023 Microdose Journal | Powered by Minimalist Blog WordPress Theme